Platform
Features
0 followers
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.
Industries
Headquarters
Employees
Links
Jeffrey Wager
3 members
Merck
217 followers
TrialX
1 follower
CHDI Foundation
5 followers
Thermo Fisher Scientific
168 followers
Genentech
150 followers
Gilead Sciences
129 followers
Biogen
115 followers
Regeneron
95 followers
Illumina
68 followers
Vertex Pharmaceuticals
59 followers
Agilent Technologies
64 followers
Explore companies